STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 98 filers reported holding STOKE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.14 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $808,354 | -34.7% | 205,166 | +76.2% | 0.00% | 0.0% |
| Q2 2023 | $1,238,023 | +125.3% | 116,465 | +76.5% | 0.00% | 0.0% |
| Q1 2023 | $549,522 | -13.5% | 65,969 | -4.2% | 0.00% | 0.0% |
| Q4 2022 | $635,347 | +89.1% | 68,835 | +163.4% | 0.00% | – |
| Q3 2022 | $336,000 | +39.4% | 26,135 | +159.7% | 0.00% | – |
| Q4 2021 | $241,000 | +0.4% | 10,065 | +40.9% | 0.00% | – |
| Q2 2021 | $240,000 | -47.9% | 7,143 | -39.8% | 0.00% | – |
| Q1 2021 | $461,000 | – | 11,857 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 16,786,713 | $562,187,000 | 75.80% |
| RTW INVESTMENTS, LP | 3,544,248 | $118,697,000 | 2.86% |
| Cormorant Asset Management, LP | 1,537,807 | $51,501,000 | 1.98% |
| Redmile Group, LLC | 2,549,506 | $85,383,000 | 1.57% |
| Birchview Capital, LP | 40,000 | $1,340,000 | 0.45% |
| HighVista Strategies LLC | 17,082 | $572,000 | 0.42% |
| Perceptive Advisors | 671,978 | $22,505,000 | 0.33% |
| GILDER GAGNON HOWE & CO LLC | 1,490,153 | $49,905,000 | 0.31% |
| Artal Group S.A. | 270,750 | $9,067,000 | 0.22% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 323 | $11,000 | 0.20% |